T Cell News and Research

Latest T Cell News and Research

Study reveals a novel therapeutic strategy to overcome tumor-induced immunosuppression

A study led by LSU Health New Orleans cancer researchers describes a novel therapeutic strategy to overcome tumor-induced immunosuppression.

29 Aug 2022

Anonymous $5.75 million gift will enable UVA to fight against rare blood cancers

A gift of more than $5.75 million from anonymous donors will allow UVA Cancer Center to speed the development of new treatments for rare blood cancers and provide more patients with these cancers access to cutting-edge clinical trials.

29 Aug 2022

Oncolytic viruses boost the immune capacity to effectively target and destroy cancer cells

The immune system has evolved to safeguard the body from a wildly diverse range of potential threats. Among these are bacterial diseases, including plague, cholera, diphtheria and Lyme disease, and viral contagions such as influenza, Ebola virus and SARS CoV-2.

29 Aug 2022

Study identifies novel neutrophil biomarkers of delayed recovery in COVID-19

Researchers map the proteomes of peripheral blood neutrophils isolated from hospitalized COVID-19 patients using high-resolution LC-MS.

25 Aug 2022

What is the association between T lymphocyte-mediated immune responses and COVID-19 severity?

Researchers examined the relationship between cell-mediated or T lymphocyte-mediated immunity and SARS-CoV-2 infection severity.

25 Aug 2022

Using the power of CRISPR to engineer better, stronger, longer-lived T cells

T cells used in immunotherapy treatments can get exhausted by the task of fighting cancer cells or get shutdown as they enter tumors.

24 Aug 2022

Experimental, genetically attenuated malaria vaccine warrants further exploration

Findings from a preliminary human study of an experimental, genetically attenuated malaria parasite immunization show this vaccine warrants further exploration.

24 Aug 2022

Researchers identify a potential new therapeutic approach to fight angioimmunoblastic T-cell lymphoma

A type of blood cell cancer called angioimmunoblastic T-cell lymphoma (AITL) can develop as mutations accumulate with age in the stem cells from which the T cells in the blood develop.

24 Aug 2022

Glucokinase activator AZD1656 shows potential benefit for diabetics with moderate to severe COVID-19

A new study examines the potential benefit of the glucokinase activator molecule AZD1656 in the ARCADIA trial.

23 Aug 2022

SARS-CoV-2 breakthrough infection induces virus-specific nasal T-cells

A new study reports that hybrid immunity induced by vaccination and previous infection induces SARS-CoV-2-specific tissue-resident T-cells in the nasal cavity.

22 Aug 2022

Researchers visualize antigen-bound T-cell receptor at atomic resolution

T cells are our immune system’s customized tools for fighting infectious diseases and tumor cells. On their surface, these special white blood cells carry a receptor that recognizes antigens.

18 Aug 2022

CD98 identified as a key mediator of pro-fibrotic and acute inflammatory responses in the lung

Researchers investigated the role of the CD98 glycoprotein in inducing an inflammatory response to SARS-CoV-2 in patients of progressive fibrosis interstitial lung diseases, including the archetypal PFILD, idiopathic pulmonary fibrosis.

18 Aug 2022

Study detects asymptomatic monkeypox virus infection

A new study published in the Annals of Internal Medicine aimed to assess the presence of MPVX in the anorectal samples of MSM who had undergone routine tests for sexually transmitted infections from 5th June to 11th July 2022.

17 Aug 2022

SARS-CoV-2 evolution within hosts and vaccination effects

A new study explores the mutational profiles within individuals infected with SARS-CoV-2.

16 Aug 2022

Superior protection with 'mix-and-match' COVID-19 booster strategy

Researchers discuss the durability and immunogenicity of homologous and heterologous booster regimens.

14 Aug 2022

In monkeys, spike-based vaccines produce some immunity based on CD8 T-cells

Scientists evaluate the role of CD8+ T-cells in vaccine protection against SARS-CoV-2 infection in rhesus macaques.

14 Aug 2022

How well does hybrid immunity protect against SARS-CoV-2 and its variants?

A new study explores the protection elicited by hybrid immunity against SARS-CoV-2 variants.

14 Aug 2022

Why is COVID-19 more severe in people older than 50?

A new study reports that the reduced efficiency of the immune response against SARS-CoV-2 could be due to the reduced diversity of both B- and T-cells.

14 Aug 2022

Experts urge FDA to include T cell responses when evaluating COVID vaccines

Now, a group of prominent scientists and physicians are urging the FDA to include in its guidance to vaccine developers a recommendation for T-cell assessment in COVID-19 vaccine clinical trials to more comprehensively measure immune response.

11 Aug 2022

Vaccines and monoclonal antibodies being developed for respiratory syncytial virus

A new study reviews recent advancements made in the development of RSV immunoprophylactic measures.

11 Aug 2022

Previous
1
...
30
31
32
33
34
35
36
...
2905
Next

T Cell News and Research

Latest T Cell News and Research

Study reveals a novel therapeutic strategy to overcome tumor-induced immunosuppression

Anonymous $5.75 million gift will enable UVA to fight against rare blood cancers

Oncolytic viruses boost the immune capacity to effectively target and destroy cancer cells

Study identifies novel neutrophil biomarkers of delayed recovery in COVID-19

What is the association between T lymphocyte-mediated immune responses and COVID-19 severity?

Using the power of CRISPR to engineer better, stronger, longer-lived T cells

Experimental, genetically attenuated malaria vaccine warrants further exploration

Researchers identify a potential new therapeutic approach to fight angioimmunoblastic T-cell lymphoma

Glucokinase activator AZD1656 shows potential benefit for diabetics with moderate to severe COVID-19

SARS-CoV-2 breakthrough infection induces virus-specific nasal T-cells

Researchers visualize antigen-bound T-cell receptor at atomic resolution

CD98 identified as a key mediator of pro-fibrotic and acute inflammatory responses in the lung

Study detects asymptomatic monkeypox virus infection

SARS-CoV-2 evolution within hosts and vaccination effects

Superior protection with 'mix-and-match' COVID-19 booster strategy

In monkeys, spike-based vaccines produce some immunity based on CD8 T-cells

How well does hybrid immunity protect against SARS-CoV-2 and its variants?

Why is COVID-19 more severe in people older than 50?

Experts urge FDA to include T cell responses when evaluating COVID vaccines

Vaccines and monoclonal antibodies being developed for respiratory syncytial virus

Immunology eBook

CellVoyant's AI-Powered Vision for the Future of Cell Therapy

Scalable, Smart, and Accessible: The Future of Lab Automation

Healthy Beginnings, Hopeful Futures: A Conversation with WHO’s Dr. Allotey

T Cell News and Research

Latest T Cell News and Research

Immunology eBook

CellVoyant's AI-Powered Vision for the Future of Cell Therapy

Scalable, Smart, and Accessible: The Future of Lab Automation

Healthy Beginnings, Hopeful Futures: A Conversation with WHO’s Dr. Allotey

Newsletters you may be interested in